Category Archives: Renu

Featured Stories
New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

Bleeding Side Effects of Pradaxa, Xarelto Have Some Doctors Concerned

Some heart doctors are raising concerns about a new class of heart drugs that include Pradaxa. Recently, a number of doctors interviewed by Reuters said they were hesitant to prescribe Pradaxa, as well as another blood thinner called Xarelto, because of concerns regarding the risk of stroke, serious bleeding ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Motion Seeks to Have Court Consider New Renu with MoistureLoc Evidence

New evidence shows that Renu with MoistureLoc Contact Lens Solution when heated in plastic containers loses antimicrobial qualities and can lead to varying forms of bacterial infections. The national law firm of Parker Waichman LLP, in light of this evidence, … Continue reading

Posted in Pharmaceuticals, Renu | Tagged , |

Evaporation of Contact Lens Solution Reduces Effectiveness

Partially evaporated contact lens solution loses much of its disinfectant ability, according to a new study. Many contact lens wearers unwittingly use partially evaporated solution, which can occur when contact lens wearers reuse solution or fail to recap their lens … Continue reading

Posted in Renu |

Bausch & Lomb Loses ReNu with MoistureLoc Insurance Case

Bausch & Lomb has lost another round in the legal wrangling involving its recalled < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc Contact Lens Solution. Last week, a federal judge ruled in favor of one of Bausch & Lomb’s insurers, Lexington Co., making it … Continue reading

Posted in Pharmaceuticals, Renu |

Multipurpose Contact Lens Solutions May Cause Eye Damage

Recent studies on some multipurpose contact lens solutions have found that such preparations can cause eye damage. One such study was detailed last week at the 8th National Congress on Optometry and Opticianry held in New York. Multipurpose contact lens … Continue reading

Posted in Pharmaceuticals, Renu |

Discovery Continues in ALL Pending ReNu with MoistureLoc Lawsuits

Lawsuits filed by people who claim they sustained non-Fusarium eye infections from Bausch & Lomb’s < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc Contact Lens Solution suffered a setback last month when a New York state court judge issued a ruling that excluded the … Continue reading

Posted in Pharmaceuticals, Renu |

Company Refocuses Marketing Efforts on ReNu

We recently wrote that Bausch & Lomb, maker of ReNu with MoistureLoc, settled around 600 lawsuits involving the < "http://www.yourlawyer.com/practice_areas/defective_drugs">recalled contact lens solution. Now, Bausch & Lomb is focusing on ReNu marketing. According to a prior report in the Associated … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Product Recalls, Renu, Toxic Substances |

Hundreds of ReNu with MoistureLoc Lawsuits Settled

Bausch & Lomb, the maker of < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc, has settled around 600 lawsuits involving the recalled contact lens solution. According to a report in the Associated Press, the settled ReNu with MoistureLoc claims have so far cost the … Continue reading

Posted in Renu |

ReNu with MoistureLoc Lost Antifungal Properties When Exposed to High Temperatures

< "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc loses much of its ability to fight fungal contamination when exposed to high temperatures for a long period of time, according to a new study published in the Archives of Ophthalmology.  ReNu with MoistureLoc was recalled … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

Tainted ReNu, AMO Contact Lens Solutions Prompt FDA Panel to Call for Better Testing

In the past several years, contact lens solutions, including < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">ReNu with MoistureLoc and < "http://www.yourlawyer.com/topics/overview/amo_complete_moisture_plus">Advanced Medical Optics Complete MoisturePlus, have been linked to potentially blinding eye infections. Now, a group of Food & Drug Administration (FDA) advisors has recommended … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

Renu with MoistureLoc, Other Contact Lens Solution Recalls Result in FDA Safety Review

Contact lens solutions have been slated for a Food & Drug Administration (FDA) safety review.  The FDA decided to embark on the review after some popular brands of contact lens solutions – including < "http://www.yourlawyer.com/topics/overview/renu_contact_solution">Renu with MoistureLoc – were linked … Continue reading

Posted in Legal News, Pharmaceuticals, Renu |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.